| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 28 |
| 1 | PREDNISOLONE | 28 |
| 2 | PREDNISOLONE ORAL | 28 |
| 3 | PREDNISOLONE ORAL SOLUTION | 28 |
| 4 | METRONIDAZOLE | 17 |
| 5 | PREDNISONE | 17 |
| 6 | TACROLIMUS | 17 |
| 7 | METRONIDAZOLE TOPICAL | 16 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 9 | TACROLIMUS OINTMENT 0.1% | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 1 | NITAZOXANIDE | 2 | 0.0057 |
| 2 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 3 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 4 | PHENAZOPYRIDINE | 4 | 0.0011 |
| 5 | IXABEPILONE | 1 | 0.0010 |
| 6 | OMADACYCLINE | 1 | 0.0006 |
| 7 | ALBENDAZOLE | 1 | 0.0005 |
| 8 | ABACAVIR SULFATE | 5 | 0.0005 |
| 9 | FOSCARNET SODIUM | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 2 | Anthelmintic [EPC] | 1 | 0.0003 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 17 | 0.0003 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0002 |
| 7 | Antimalarial [EPC] | 2 | 0.0002 |
| 8 | Penem Antibacterial [EPC] | 6 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |